tradingkey.logo
搜尋

Artivion Inc

AORT
添加自選
27.015USD
+0.915+3.51%
收盤 07-28 16:00美東報價延遲15分鐘
1.31B總市值
105.28本益比TTM

關於 Artivion Inc 公司

Artivion, Inc. is a medical device company focused on developing solutions that address cardiac and vascular surgeons’ challenges in treating patients with aortic diseases. The Company is engaged in the manufacturing, processing, and distribution of medical devices and implantable human tissues used in cardiac and vascular surgical procedures for patients with aortic disease. It has four major product families: aortic stent grafts, surgical sealants, On-X mechanical heart valves and related surgical products, and implantable cardiac and vascular human tissues. Its Medical Devices segment includes sales of aortic stent grafts, surgical sealants, On-X products, and other product revenues. Its Preservation Services segment includes services for the preservation of cardiac and vascular implantable human tissues. Aortic stent grafts include aortic arch stent grafts, abdominal stent grafts, and synthetic vascular grafts. Surgical sealants include its BioGlue Surgical Adhesive products.

Artivion Inc簡介

公司代碼AORT
公司名稱Artivion Inc
上市日期Feb 12, 1993
CEOMackin (James Patrick)
員工數量1600
證券類型Ordinary Share
年結日Feb 12
公司地址1655 Roberts Boulevard N W
城市KENNESAW
上市交易所NASDAQ OMX NASDAQ Basic NYSE
國家United States of America
郵編30144
電話17704193355
網址https://artivion.com/
公司代碼AORT
上市日期Feb 12, 1993
CEOMackin (James Patrick)

Artivion Inc公司高管

名稱
名稱/職務
職務
持股
持股變動
Mr. John E. Davis
Mr. John E. Davis
Senior Vice President - Global Sales and Marketing
Senior Vice President - Global Sales and Marketing
203.01K
+7.32%
Mr. Lance A. Berry, CPA
Mr. Lance A. Berry, CPA
Chief Financial Officer, Chief Operating Officer, Executive Vice President - Finance, Treasurer
Chief Financial Officer, Chief Operating Officer, Executive Vice President - Finance, Treasurer
167.55K
+10.84%
Mr. Daniel J. Bevevino
Mr. Daniel J. Bevevino
Independent Director
Independent Director
157.64K
+4.81%
Mr. Thomas F. Ackerman
Mr. Thomas F. Ackerman
Independent Director
Independent Director
157.47K
+4.81%
Mr. Jon W. Salveson
Mr. Jon W. Salveson
Independent Director
Independent Director
137.42K
+5.51%
Ms. Amy D. Horton, CPA
Ms. Amy D. Horton, CPA
Chief Accounting Officer, Vice President
Chief Accounting Officer, Vice President
134.82K
+4.40%
Mr. James W. Bullock
Mr. James W. Bullock
Independent Director
Independent Director
76.22K
+9.94%
Mr. Jeffrey H. (Jeff) Burbank
Mr. Jeffrey H. (Jeff) Burbank
Lead Independent Director
Lead Independent Director
61.37K
+12.34%
Mr. Andrew M. Green
Mr. Andrew M. Green
Vice President - Regulatory Affairs
Vice President - Regulatory Affairs
60.26K
+44.40%
Dr. Marshall S. Stanton, M.D.
Dr. Marshall S. Stanton, M.D.
Senior Vice President, Clinical Research and Chief Medical Officer
Senior Vice President, Clinical Research and Chief Medical Officer
39.13K
+34.61%
查看更多
名稱
名稱/職務
職務
持股
持股變動
Mr. John E. Davis
Mr. John E. Davis
Senior Vice President - Global Sales and Marketing
Senior Vice President - Global Sales and Marketing
203.01K
+7.32%
Mr. Lance A. Berry, CPA
Mr. Lance A. Berry, CPA
Chief Financial Officer, Chief Operating Officer, Executive Vice President - Finance, Treasurer
Chief Financial Officer, Chief Operating Officer, Executive Vice President - Finance, Treasurer
167.55K
+10.84%
Mr. Daniel J. Bevevino
Mr. Daniel J. Bevevino
Independent Director
Independent Director
157.64K
+4.81%
Mr. Thomas F. Ackerman
Mr. Thomas F. Ackerman
Independent Director
Independent Director
157.47K
+4.81%
Mr. Jon W. Salveson
Mr. Jon W. Salveson
Independent Director
Independent Director
137.42K
+5.51%
Ms. Amy D. Horton, CPA
Ms. Amy D. Horton, CPA
Chief Accounting Officer, Vice President
Chief Accounting Officer, Vice President
134.82K
+4.40%

常見問題

Artivion Inc的前五大股東是誰?

Artivion Inc的前五大股東如下:Mr. John E. Davis

有多少機構持有Artivion Inc(AORT)的股份?

截至2026Q1,共有449家機構持有Artivion Inc的股份,合計持有的股份價值約為45.29M,占公司總股份的93.40% 。與2025Q4相比,機構持股有所增加,增幅為501666.00。

哪個業務部門對Artivion Inc的收入貢獻最大?

在2026Q1,Aortic stent grafts業務部門對Artivion Inc的收入貢獻最大,創收159.37M,占總收入的36.11% 。
tradingkey.logo
風險提示:我們的網站和行動應用程式僅提供關於某些投資產品的一般資訊。Finsights 不提供財務建議或對任何投資產品的推薦,且提供此類資訊不應被解釋為 Finsights 提供財務建議或推薦。
投資產品存在重大投資風險,包括可能損失投資的本金,且可能並不適合所有人。投資產品的過去表現並不代表其未來表現。
Finsights 可能允許第三方廣告商或關聯公司在我們的網站或行動應用程式的任何部分放置或投放廣告,並可能根據您與廣告的互動情況獲得報酬。
© 版權所有: FINSIGHTS MEDIA PTE. LTD. 版權所有